BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18585553)

  • 1. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY; Houser SM; Rodriguez HP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1017-1018. PubMed ID: 17547999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY; Houser SM; Rodriguez HP
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):658-9. PubMed ID: 17418269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable immunotherapy: recommendations for safe allergen vial preparation in the office setting.
    Lay PC
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):223-5. PubMed ID: 19395969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 6. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 7. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 11. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP releases revision of chapter on sterile compounding: new version of USP chapter 797 emphasizes personnel.
    Thompson CA
    Am J Health Syst Pharm; 2008 Jan; 65(2):104, 111. PubMed ID: 18192250
    [No Abstract]   [Full Text] [Related]  

  • 15. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 16. Misinterpretations of United States pharmacopeia chapter <797>.
    McElhiney LF
    Int J Pharm Compd; 2012; 16(1):6-10. PubMed ID: 23050305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basics of compounding sterile preparations: nomenclature and considerations.
    Allen LV
    Int J Pharm Compd; 2014; 18(4):313-7. PubMed ID: 25474860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.